New Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed

Center one labs inc. is pleased to announce that its utterly owned subsidiary akome biotech ltd. (“akome”) has started out the development of a next-generation psychedelic drug formulation for the…

Continue ReadingNew Psychedelic Drug Formula Believed to Work to Mitigate Neurological Damage Due to Stroke, Provisional Patent Application Filed

End of content

No more pages to load